|
KLF10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76599999999194E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1027999999923E-05 |
| Normal-vs-Stage2 |
2.58659999996524E-06 |
| Normal-vs-Stage3 |
2.26759999999437E-05 |
| Normal-vs-Stage4 |
4.11970000002704E-06 |
| Stage1-vs-Stage2 |
1.878580E-01 |
| Stage1-vs-Stage3 |
8.446200E-01 |
| Stage1-vs-Stage4 |
2.544200E-01 |
| Stage2-vs-Stage3 |
3.103400E-01 |
| Stage2-vs-Stage4 |
6.972800E-01 |
| Stage3-vs-Stage4 |
4.881400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.23429999999247E-05 |
| Normal-vs-AfricanAmerican |
2.580200E-04 |
| Normal-vs-Asian |
9.62340000000284E-05 |
| Caucasian-vs-AfricanAmerican |
5.522800E-01 |
| Caucasian-vs-Asian |
5.581000E-01 |
| AfricanAmerican-vs-Asian |
8.780400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.47249999999022E-06 |
| Normal-vs-Female |
2.12539999999706E-05 |
| Male-vs-Female |
1.454960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.4314999999997E-05 |
| Normal-vs-Age(41-60Yrs) |
1.60229999999206E-05 |
| Normal-vs-Age(61-80Yrs) |
4.50910000004967E-06 |
| Normal-vs-Age(81-100Yrs) |
2.915200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.510800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.242000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.205000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.973600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.640800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.390200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.127600E-02 |
| Classical-VS-Follicular |
5.584100E-02 |
| Classical-VS-Other |
1.341770E-01 |
| Classical-VS-Normal |
4.14469999999723E-05 |
| Tall-VS-Follicular |
8.408400E-01 |
| Tall-VS-Other |
2.833400E-01 |
| Tall-VS-Normal |
4.0326000000368E-06 |
| Follicular-VS-Other |
5.648800E-01 |
| Follicular-VS-Normal |
3.15250000004763E-06 |
| Other-VS-Normal |
3.14199999995601E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.68569999994916E-06 |
| Normal-vs-N1 |
2.40509999999139E-05 |
| N0-vs-N1 |
4.555200E-01 |
|
|
